Global CRISPR-based Gene Editing Market Size To Exceed USD 17.78 Billion By 2035 | CAGR of 14.63%
Category: HealthcareGlobal CRISPR-based Gene Editing Market Size To Exceed USD 17.78 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global CRISPR-based Gene Editing Market Size is expected to grow from USD 3.96 Billion in 2024 to USD 17.78 Billion by 2035, at a CAGR of 14.63% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the “Global CRISPR-based Gene Editing Market Size, Share, and COVID-19 Impact Analysis, By Product & Service (Products and Services), By Application (Biomedical and Agricultural), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/crispr-based-gene-editing-market
The worldwide market for CRISPR-based gene editing is centered on the study, creation, marketing, and usage of CRISPR technology for accurate genetic alteration. The CRISPR-based gene editing market includes a broad range of products and services, such as reagents, delivery methods, CRISPR gene editing tools, and associated software platforms utilized in both commercial and academic contexts. It is essential to the advancement of genetic research since it makes it possible to modify specific DNA sequences for applications including functional genomics, disease modeling, pharmaceutical development, and agricultural improvement. The growing application of precision medicine, along with developments in genomic sequencing and editing technologies, is a key driver of the global CRISPR gene-editing market. This expansion is due to a number of variables, including the prevalence of genetic illnesses, government assistance, increased investments in biotechnology, and scientific and technological breakthroughs. Advances in CRISPR technology and applications are improving gene editing's accuracy, effectiveness, and adaptability, which is significantly accelerating market expansion. However, growth in the CRISPR-based gene editing market is restricted by issues with effective delivery methods, intellectual property disputes, and low public awareness.
The products segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product & service, the CRISPR-based gene editing market is divided into products and services. Among these, the products segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The market has benefited greatly from the rising need for accurate and effective gene editing instruments as well as continuous improvements in product offerings.
The biomedical segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the CRISPR-based gene editing market is divided into biomedical and agricultural. Among these, the biomedical segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Numerous important factors, such as the rising incidence of genetic illnesses and tumors and the notable developments in CRISPR technology, are propelling the biomedical sector.
North America is expected to hold the majority share of the global CRISPR-based gene editing market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global v market during the forecast period. Many agricultural firms are working on the commercialization of CRISPR-edited crops because crops treated with CRISPR-based gene editing are not considered genetically modified organisms (GMOs) in the United States. North America due to large expenditures made by biotech and pharmaceutical companies better healthcare facilities, increased per capita income, early access to authorized treatments, and the existence of cutting-edge research facilities and labs.
Asia Pacific is anticipated to grow at the fastest pace in the global CRISPR-based gene editing market during the forecast period. The area benefits from a sizable patient base with unmet medical requirements, which raises demand for cutting-edge genetic medicines. In the global CRISPR landscape, cooperation among academic institutions, biotech startups, and multinational corporations will bolster Asia Pacific's standing as a high-growth region.
Major vendors in the global CRISPR-based gene editing market are Danaher, GenScript, Revvity Inc., Bio-Techne, Merck KGaA, Tocris Bioscience, Bio-Rad Laboratories, New England Biolabs, Inc., OriGene Technologies, Inc., Thermo Fisher Scientific, Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In January 2024, Casgevy which was approved by the U.S. FDA for the first time as a CRISPR-based gene-editing therapy for sickle cell disease and transfusion-dependent β-thalassemia, has been announced by CRISPR Therapeutics AG and Vertex Pharmaceuticals. This significant achievement represents a revolutionary development in genetic medicine, providing patients with severe hereditary blood abnormalities with a one-time curative treatment.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the CRISPR-based gene editing market based on the below-mentioned segments:
Global CRISPR-based Gene Editing Market, By Product & Service
- Products
- Services
Global CRISPR-based Gene Editing Market, By Application
- Biomedical
- Agricultural
Global CRISPR-based Gene Editing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?